Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment. Now ...

Weight-loss jabs may raise the risk of kidney cancer—a 'silent killer' now striking more under-50s—even as new research suggests they could protect against other tumours. The alarm comes from the ...

People with obesity were twice as likely to get cancer and more likely to die of it, compared to those who had weight loss surgery, study found.

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Weight-loss injections could help to reduce the risk of cancer. This finding comes at a time when obesity rates continue to rise globally, with significant implications for public health policies and ...

Exciting new findings indicate that GLP-1 weight-loss medications might dramatically reduce the likelihood of 10 types of ...

Millions of Americans have turned to weight-loss injections originally developed to treat diabetes—and now, research suggests that these medications may offer a surprising additional benefit: ...

Cognitive dysfunction in kidney cancer survivors is linked to treatment burden, stress, and fatigue, affecting daily ...

Symptoms of stage 3 RCC vary; some patients experience blood in the urine, flank pain, fatigue, weight loss, or a palpable ...